Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Giardia lamblia | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0.0063 | 0.0305 | 1 |
Loa Loa (eye worm) | carboxylesterase | 0.0201 | 0.3445 | 0.3445 |
Trypanosoma cruzi | 3-hydroxy-3-methylglutaryl-CoA reductase, putative | 0.0134 | 0.1928 | 0.1878 |
Schistosoma mansoni | hydroxymethylglutaryl-CoA reductase (NADPH) | 0.0134 | 0.1928 | 0.1928 |
Loa Loa (eye worm) | hypothetical protein | 0.0134 | 0.1928 | 0.1928 |
Brugia malayi | CHE-14 protein | 0.0055 | 0.0129 | 0.0129 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0052 | 0.0061 | 0.0061 |
Brugia malayi | Carboxylesterase family protein | 0.0201 | 0.3445 | 0.3445 |
Echinococcus granulosus | hydroxymethylglutaryl coenzyme A reductase | 0.0134 | 0.1928 | 0.1928 |
Echinococcus granulosus | Niemann Pick C1 protein | 0.0055 | 0.0129 | 0.0129 |
Trypanosoma brucei | developmentally regulated phosphoprotein | 0.0489 | 1 | 1 |
Schistosoma mansoni | patched 1 | 0.0055 | 0.0129 | 0.0129 |
Loa Loa (eye worm) | CMGC/MAPK/ERK1 protein kinase | 0.0052 | 0.0061 | 0.0061 |
Echinococcus multilocularis | Pyruvate dehydrogenase (lipoamide) kinase | 0.0489 | 1 | 1 |
Echinococcus granulosus | Protein patched homolog 1 | 0.0055 | 0.0129 | 0.0129 |
Onchocerca volvulus | 0.005 | 0 | 0.5 | |
Echinococcus multilocularis | acetylcholinesterase | 0.0201 | 0.3445 | 0.3445 |
Loa Loa (eye worm) | abnormal chemotaxis protein 14 | 0.0055 | 0.0129 | 0.0129 |
Trypanosoma cruzi | 3-hydroxy-3-methylglutaryl-CoA reductase | 0.0134 | 0.1928 | 0.1878 |
Loa Loa (eye worm) | hypothetical protein | 0.0201 | 0.3445 | 0.3445 |
Echinococcus granulosus | carboxylesterase 5A | 0.0201 | 0.3445 | 0.3445 |
Echinococcus granulosus | mitogen activated protein kinase 3 | 0.0052 | 0.0061 | 0.0061 |
Toxoplasma gondii | ATPase/histidine kinase/DNA gyrase B/HSP90 domain-containing protein | 0.0198 | 0.338 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0055 | 0.0129 | 0.278 |
Echinococcus multilocularis | acetylcholinesterase | 0.0201 | 0.3445 | 0.3445 |
Onchocerca volvulus | Protein ultraspiracle homolog | 0.005 | 0 | 0.5 |
Trichomonas vaginalis | 3-hydroxy-3-methylglutaryl-coenzyme A reductase, putative | 0.0063 | 0.0305 | 1 |
Trypanosoma cruzi | developmentally regulated phosphoprotein, putative | 0.0489 | 1 | 1 |
Echinococcus multilocularis | mitogen activated protein kinase 3 | 0.0052 | 0.0061 | 0.0061 |
Loa Loa (eye worm) | hypothetical protein | 0.0055 | 0.0129 | 0.0129 |
Echinococcus granulosus | acetylcholinesterase | 0.0201 | 0.3445 | 0.3445 |
Echinococcus granulosus | acetylcholinesterase | 0.0201 | 0.3445 | 0.3445 |
Toxoplasma gondii | pyruvate dehydrogenase kinase, putative | 0.0171 | 0.2761 | 0.8134 |
Brugia malayi | Carboxylesterase family protein | 0.0201 | 0.3445 | 0.3445 |
Loa Loa (eye worm) | hypothetical protein | 0.0489 | 1 | 1 |
Echinococcus multilocularis | arachidonate 5 lipoxygenase | 0.0057 | 0.0161 | 0.0161 |
Schistosoma mansoni | pyruvate dehydrogenase | 0.0461 | 0.9381 | 0.9381 |
Trichomonas vaginalis | 3-hydroxy-3-methylglutaryl-coenzyme A reductase, putative | 0.0063 | 0.0305 | 1 |
Echinococcus multilocularis | Niemann Pick C1 protein | 0.0055 | 0.0129 | 0.0129 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.0201 | 0.3445 | 0.3445 |
Echinococcus multilocularis | protein patched | 0.0055 | 0.0129 | 0.0129 |
Leishmania major | pyruvate dehydrogenase (lipoamide) kinase, putative | 0.0171 | 0.2761 | 0.2716 |
Schistosoma mansoni | pyruvate dehydrogenase | 0.0489 | 1 | 1 |
Brugia malayi | MAP kinase sur-1 | 0.0052 | 0.0061 | 0.0061 |
Schistosoma mansoni | lipoxygenase | 0.0057 | 0.0161 | 0.0161 |
Echinococcus granulosus | mitogen activated protein kinase | 0.0052 | 0.0061 | 0.0061 |
Onchocerca volvulus | Steroid hormone receptor family member cnr14 homolog | 0.005 | 0 | 0.5 |
Mycobacterium ulcerans | hydroxymethylglutaryl-coenzyme a (HMG-CoA) reductase | 0.0134 | 0.1928 | 0.5 |
Schistosoma mansoni | pyruvate dehydrogenase | 0.0461 | 0.9381 | 0.9381 |
Trypanosoma brucei | 3-hydroxy-3-methylglutaryl-CoA reductase, putative | 0.0134 | 0.1928 | 0.1878 |
Echinococcus granulosus | sterol regulatory element binding protein | 0.0055 | 0.0129 | 0.0129 |
Echinococcus multilocularis | carboxylesterase 5A | 0.0201 | 0.3445 | 0.3445 |
Schistosoma mansoni | niemann-pick C1 (NPC1) | 0.0055 | 0.0129 | 0.0129 |
Echinococcus multilocularis | protein dispatched 1 | 0.0055 | 0.0129 | 0.0129 |
Echinococcus granulosus | arachidonate 5 lipoxygenase | 0.0057 | 0.0161 | 0.0161 |
Loa Loa (eye worm) | hypothetical protein | 0.0201 | 0.3445 | 0.3445 |
Echinococcus multilocularis | Pyruvate dehydrogenase (lipoamide) kinase | 0.0489 | 1 | 1 |
Leishmania major | 3-hydroxy-3-methylglutaryl-CoA reductase | 0.0134 | 0.1928 | 0.1878 |
Trypanosoma brucei | pyruvate dehydrogenase (lipoamide) kinase, putative | 0.0171 | 0.2761 | 0.2716 |
Onchocerca volvulus | Bile acid receptor homolog | 0.005 | 0 | 0.5 |
Echinococcus multilocularis | hydroxymethylglutaryl coenzyme A reductase | 0.0134 | 0.1928 | 0.1928 |
Echinococcus multilocularis | mitogen activated protein kinase | 0.0052 | 0.0061 | 0.0061 |
Trichomonas vaginalis | 3-hydroxy-3-methylglutaryl-coenzyme A reductase, putative | 0.0063 | 0.0305 | 1 |
Leishmania major | developmentally regulated phosphoprotein-like protein | 0.0489 | 1 | 1 |
Echinococcus granulosus | Pyruvate dehydrogenase lipoamide kinase | 0.0489 | 1 | 1 |
Loa Loa (eye worm) | acetylcholinesterase 1 | 0.0201 | 0.3445 | 0.3445 |
Trypanosoma cruzi | pyruvate dehydrogenase (lipoamide) kinase, putative | 0.0171 | 0.2761 | 0.2716 |
Brugia malayi | Hydroxymethylglutaryl-coenzyme A reductase family protein | 0.0134 | 0.1928 | 0.1928 |
Echinococcus multilocularis | sterol regulatory element binding protein | 0.0055 | 0.0129 | 0.0129 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.